Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 7Terminated 3Unknown 2Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Carcinoma, Renal Cell 14Neoplasm Metastasis 6Kidney Neoplasms 5Breast Neoplasms 5Carcinoma, Non-Small-Cell Lung 4Glioblastoma 3Urinary Bladder Neoplasms 2Prostatic Neoplasms 2Neoplasms 2Uveal Melanoma 1Urethral Neoplasms 1Thyroid Neoplasms 1Thymoma 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Ovarian Neoplasms 1Lung Neoplasms 1Hormone Refractory Prostate Cancer 1Glioma 1Gastrointestinal Stromal Tumors 1Gastrointestinal Neoplasms 1Fatigue 1Endometrial Neoplasms 1Colorectal Neoplasms 1Carcinoma 1Carcinoid Tumor 1Brain Neoplasms 1

Interventions

Gemcitabine 7Cystectomy 5Cisplatin 5durvalumab 4Neoadjuvant Therapy 4Mitomycin 4atezolizumab 3Transurethral Resection of Bladder 3Nivolumab 3Epirubicin 3Chemoradiotherapy 3BCG Vaccine 3Anesthesia, Spinal 3tislelizumab 2disitamab vedotin 2catumaxomab 2Vitamin E 2Urinary Diversion 2Sunitinib 2Selenium 2Robotic Surgical Procedures 2Multiparametric Magnetic Resonance Imaging 2Magnetic Resonance Imaging 2Immunohistochemistry 2Fentanyl 2Docetaxel 2Diathermy 2Cystoscopy 2Chemoprevention 2BCG Connaught 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Urinary Bladder Neoplasms × Sunitinib × Clear all
NCT01118039 2013-08-07

Sunitinib Malate in Treating Patients With Locally Recurrent, Locally Advanced, Unresectable, or Metastatic Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2 Unknown
41 enrolled
Genitourinary

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00818350 2009-01-07

Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer

Campania Younger Oncologists Association

Phase 1/2 Unknown
25 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡